Showing results (51-60 of 651) with videos related to
Sort By:
Pageof 66
International Immunology|May 1, 1993
Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouseP Sempé, S Ezine, J Marvel, et al.Immunogenetics|January 1, 1990
Heterogeneity of HLA genetic factors in IDDM susceptibilityM Martell, A Marcadet, A Moine, et al.The American Journal of Medicine|March 1, 1988
POEMS syndrome presenting as systemic sclerosis. Clinical and pathologic study of a case with microangiopathic glomerular lesionsJ P Viard, P Lesavre, C Boitard, et al.Diabetes & Metabolism|February 1, 1997
Insulin responses to intravenous glucose, intravenous arginine and a hyperglycaemic clamp in ICA-positive subjects with different degrees of glucose toleranceB Rakotoambinina, J Timsit, I Deschamps, et al.Diabetes|May 4, 2001
A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetesD Dubois-Laforgue, H Hendel, S Caillat-Zucman, et al.European Journal of Immunology|June 30, 1998
Identification of mimicry peptides based on sequential motifs of epitopes derived from 65-kDa glutamic acid decarboxylaseJ M Bach, H Otto, G Jung, et al.Diabetes Care|November 1, 1995
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patientsB Rakotoambinina, J Timsit, I Deschamps, et al.American Journal of Hypertension|February 1, 1993
Proliferation and Na+/H+ antiport activity in human fibroblasts from type I diabetic patients with nephropathyK Soussan, E Dausse, T Hannedouche, et al.Journal of Autoimmunity|February 1, 1992
Autoantibodies against pancreatic beta-cells: characterization by western blot analysis in the non-obese diabetic (NOD) mouseM C Villà, C Bécourt, H P Gia, et al.Diabetes|July 1, 1988
Inhibition of insulin release in vitro mediated by mononuclear cells from diabetic patients treated with cyclosporin A or placeboM Debray-Sachs, P Sai, G Feutren, et al.Pageof 66